David M. Morens, 78, a former senior adviser at the National Institute of Allergy and Infectious Diseases, was indicted April 28, 2026, on four federal counts: conspiracy against the United States, destruction or falsification of records in a federal investigation, concealment or removal of federal records, and aiding and abetting [1]. The indictment was returned in the District of Maryland and filed through the U.S. Attorney's Office in Baltimore [1].
The charges stem from an alleged scheme to evade Freedom of Information Act requests related to COVID-19 research grants and a bat coronavirus grant awarded to the Wuhan Institute of Virology [1]. FOIA, codified at 5 U.S.C. § 552, requires federal agencies to disclose requested records unless a specific statutory exemption applies. Federal law separately prohibits concealment, falsification, or destruction of government records, including those sought in the course of official investigations. Morens served as a senior adviser to NIAID Director Anthony Fauci during the pandemic period central to the allegations [1].
The indictment was announced by the Justice Department's Office of Public Affairs and reflects enforcement priorities set under Deputy Attorney General Todd Blanche, who has overseen the department's accountability-focused posture toward pandemic-era federal conduct [1]. The case falls within the District of Maryland's jurisdiction and was developed in coordination with the FBI [1]. No trial date has been publicly announced, and Morens has not entered a plea on the record as of the indictment's filing.
The prosecution carries significant procedural weight. A conviction on the conspiracy count alone, under 18 U.S.C. § 371, carries a maximum sentence of five years. The records-destruction and concealment counts carry additional exposure. The government will need to establish that Morens acted knowingly and willfully to circumvent FOIA obligations, a mens rea threshold that defense counsel will contest. The case is likely to draw parallel scrutiny of institutional practices at NIH and NIAID regarding records management during the COVID-19 pandemic, and congressional oversight committees have shown sustained interest in pandemic-origin documentation. How courts treat the scope of FOIA-evasion conduct as a predicate for obstruction charges may produce rulings with durable procedural implications beyond this case.